Terms: = Prostate cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
6 results:
1. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
[TBL] [Abstract] [Full Text] [Related]
2.
Stolarova L; Kleiblova P; Janatova M; Soukupova J; Zemankova P; Macurek L; Kleibl Z
Cells; 2020 Dec; 9(12):. PubMed ID: 33322746
[TBL] [Abstract] [Full Text] [Related]
3. Truncating and missense ppm1d mutations in early-onset and/or familial/hereditary prostate cancer patients.
Cardoso M; Paulo P; Maia S; Teixeira MR
Genes Chromosomes Cancer; 2016 Dec; 55(12):954-961. PubMed ID: 27401275
[TBL] [Abstract] [Full Text] [Related]
4. ppm1d as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract] [Full Text] [Related]
5. wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation.
Song JY; Ryu SH; Cho YM; Kim YS; Lee BM; Lee SW; Choi J
Cell Death Dis; 2013 Aug; 4(8):e744. PubMed ID: 23907458
[TBL] [Abstract] [Full Text] [Related]
6. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians' Health Study.
Margalit DN; Kasperzyk JL; Martin NE; Sesso HD; Gaziano JM; Ma J; Stampfer MJ; Mucci LA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):28-32. PubMed ID: 22079732
[TBL] [Abstract] [Full Text] [Related]
